The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age. (2021)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05558-1
PubMed Identifier: 34488846
Publication URI: http://europepmc.org/abstract/MED/34488846
Type: Journal Article/Review
Volume: 22
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215